Skip to content
EW Edwards Lifesciences Corp NYSE
82.01 USD 0.44% +0.36
OPEN 81.54
DAY RANGE 82.10 - 81.30
52 WEEK RANGE 107.92 - 67.13
Interactive Brokers Logotype

Buy EW stocks now with Interactive Brokers – the most advanced investment platform

Valuations metrics

Market capitalization 49.7B
Enterprise value 49.2B
Trailing pe 33.888428
Forward pe 28.377163
Peg ratio 28.377163
Price to sales ttm 9.037947
Price to book mrq 8.313229
Enterprise to revenue 8.95
Enterprise to ebitda 25.621


Fiscal year ends 2022-12-31
Most recent quarter 2023-03-31
Profit margin 0.27065
Operating margin 0.32386002
Return on assets ttm 0.13045
Return on equity ttm 0.25007
Income statement
Revenue ttm 5.5B
Revenue per share ttm 8.939
Quarterly revenue growth 0.088
Gross profit ttm 4.3B
Ebitda 1.9B
Net income to common ttm 1.5B
Diluted eps ttm 2.42
Quarterly earnings growth yoy -0.089
Balance sheet
Total cash mrq 1.3B
Total cash per share mrq 2.069
Total debt mrq 687.8M
Total debt to equity mrq 11.346
Current ratio mrq 3.01
Book value per share mrq 9.865
Cash flow
Operating cash flow ttm 1.2B
Levered free cash flow ttm 1B

Stock statistics

Shares outstanding 606.2M
Float shares 600.6M
Avg 10 volume 2.5M
Avg 30 volume 2.6M
Shares short 9.8M
Short ratio 3.66
Short percent of shares outstanding 0.0164
Percent held by insiders 0.00838
Percent held by institutions 0.87234

Stock price summary

Fifty two week low 67.13
Fifty two week high 107.92
Fifty two week change -22.973
Beta 1.015482
Day 50 ma 85.0532
Day 200 ma 82.11225

Dividends and splits

Last split factor 3-for-1 split
Last split date 2020-06-01

Edwards Lifesciences (EW) company profile

Edwards Lifesciences (NYSE: EW) is an American company that designs, develops, and markets products and services to treat heart-related diseases. It offers transcatheter heart and surgical heart valves, heart valve repair, cardiac cannula, hemodynamic monitoring, pressure monitoring, vascular surgery, and investigational devices. Additionally, it provides surgical heart valve therapy products, including pericardial valves for aortic and mitral surgical valve replacement, aortic heart valves; annuloplasty rings; cardiac cannula devices; a beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation.